Clinical Trial Update: Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions [NA]

View source ↗

Summary

A clinical trial evaluating a bioresorbable sirolimus-eluting scaffold for de novo coronary artery lesions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis

Drugs mentioned

• Bioresorbable Sirolimus-eluting scaffold (sirolimus-eluting scaffold)

Snippet

Sponsor: Xijing Hospital | Conditions: De Novo Stenosis, Coronary Artery Disease | NA | Status: RECRUITING